ProfileGDS5822 / ILMN_3121522
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 34% 9% 48% 12% 14% 18% 13% 4% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.534
GSM1276600PDAC Late Ablation Control 211.59
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 118.748
GSM1276603PDAC Late Ablation 29.512
GSM1276604PDAC Late Ablation 39.814
GSM1303940PDAC Late Ablation_anti-CTLA4 112.118
GSM1303941PDAC Late Ablation_anti-CTLA4 28.113
GSM1303942PDAC Late Ablation_anti-CTLA4 33.54